Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawasaki, T.
Right arrow Articles by Hoylaerts, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawasaki, T.
Right arrow Articles by Hoylaerts, M. F.
Related Collections
Right arrow Hemostasis, Thrombosis, and Vascular Biology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 96 No. 1 (July 1), 2000: pp. 153-160

Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice

Tomihisa Kawasaki, Mieke Dewerchin, Henri R. Lijnen, Jos Vermylen, and Marc F. Hoylaerts

From the Center for Molecular and Vascular Biology, University of Leuven, and Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, Leuven, Belgium

The role of plasminogen activator inhibitor-1 (PAI-1) in the plasma, blood platelets, and vessel wall during acute arterial thrombus formation was investigated in gene-deficient mice. Photochemically induced thrombosis in the carotid artery was analyzed via transillumination. In comparison to thrombosis in C57BL/6J wild-type (wt) mice (113 ± 19 × 106 arbitrary light units [AU] n = 15, mean ± SEM), thrombosis in PAI-1-/- mice (40 ± 10 × 106 AU, n = 13) was inhibited (P < .01), indicating that PAI-1 controls fibrinolysis during thrombus formation. Systemic administration of murine PAI-1 into PAI-1-/- mice led to a full recovery of thrombotic response. Occurrence of fibrinolytic activity was confirmed in alpha 2-antiplasmin (alpha 2-AP)-deficient mice. The sizes of thrombi developing in wt mice, in alpha 2-AP+/- and alpha 2-AP-/- mice were 102 ± 35, 65 ± 8.1, and 13 ± 6.1 × 106 AU, respectively (n = 6 each) (P < .05), compatible with functional plasmin inhibition by alpha 2-AP. In contrast, thrombi in wt mice, t-PA-/- and u-PA-/- mice were comparable, substantiating efficient inhibition of fibrinolysis by the combined PAI-1/alpha 2-AP action. Platelet depletion and reconstitution confirmed a normal thrombotic response in wt mice, reconstituted with PAI-1-/- platelets, but weak thrombosis in PAI-1-/- mice reconstituted with wt platelets. Accordingly, murine (wt) PAI-1 levels in platelet lysates and releasates were 0.43 ± 0.09 ng/109 platelets and plasma concentrations equaled 0.73 ± 0.13 ng/mL. After photochemical injury, plasma PAI-1 rose to 2.9 ± 0.7 ng/mL (n = 9, P < .01). The plasma rise was prevented by ligating the carotid artery. Hence, during acute thrombosis, fibrinolysis is efficiently prevented by plasma alpha 2-AP, but also by vascular PAI-1, locally released into the circulation after endothelial injury.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. F. Bodary
Links Between Adipose Tissue and Thrombosis in the Mouse
Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2284 - 2291.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. P. Fay, N. Garg, and M. Sunkar
Vascular Functions of the Plasminogen Activation System
Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1231 - 1237.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Schafer, M. R. Schroeter, C. Dellas, M. Puls, M. Nitsche, E. Weiss, G. Hasenfuss, and S. V. Konstantinides
Plasminogen Activator Inhibitor-1 From Bone Marrow-Derived Cells Suppresses Neointimal Formation After Vascular Injury in Mice
Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1254 - 1259.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
V. M Silva, N. Corson, A. Elder, and G. Oberdorster
The Rat Ear Vein Model for Investigating In Vivo Thrombogenicity of Ultrafine Particles (UFP)
Toxicol. Sci., June 1, 2005; 85(2): 983 - 989.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. M. Day, J. L. Reeve, B. Pedersen, D. M Farris, D. D. Myers, M. Im, T. W. Wakefield, N. Mackman, and W. P. Fay
Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall
Blood, January 1, 2005; 105(1): 192 - 198.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. C. Pitchford, Y. Riffo-Vasquez, A. Sousa, S. Momi, P. Gresele, D. Spina, and C. P. Page
Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation
Blood, January 15, 2004; 103(2): 639 - 647.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Schafer, K. Muller, A. Hecke, E. Mounier, J. Goebel, D. J. Loskutoff, and S. Konstantinides
Enhanced Thrombosis in Atherosclerosis-Prone Mice Is Associated With Increased Arterial Expression of Plasminogen Activator Inhibitor-1
Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2097 - 2103.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Peng, N. Bhatia, A. C. Parker, Y. Zhu, and W. P. Fay
Endogenous Vitronectin and Plasminogen Activator Inhibitor-1 Promote Neointima Formation in Murine Carotid Arteries
Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 934 - 939.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
A. Manganaro, M. Ruggeri, G. Ando, M. Longo, and G. Vita
Endothelial Functions in Pathophysiology of Thrombosis and Fibrinolysis: Late Spontaneous Recanalization of an Occluded Internal Carotid Artery: A Case Report
Angiology, January 1, 2002; 53(1): 99 - 103.
[Abstract] [PDF]


Home page
CirculationHome page
M. B. DeYoung, C. Tom, and D. A. Dichek
Plasminogen Activator Inhibitor Type 1 Increases Neointima Formation in Balloon-Injured Rat Carotid Arteries
Circulation, October 16, 2001; 104(16): 1972 - 1971.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Kawasaki, M. Dewerchin, H. R. Lijnen, I. Vreys, J. Vermylen, and M. F. Hoylaerts
Mouse Carotid Artery Ligation Induces Platelet-Leukocyte-Dependent Luminal Fibrin, Required for Neointima Development
Circ. Res., February 2, 2001; 88(2): 159 - 166.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020